Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Atara Biotherapeutics Inc (ATRA)

NASDAQ
Currency in USD
Disclaimer
0.6600
-0.0307(-4.44%)
Closed
After Hours
0.6371-0.0229(-3.4697%)

ATRA Comments

The reason why people don't make it in crypto is because they haven't made a good decision towards their investments, this man has been the only one that has helped me out in some of my trade which has really helped me alot I pray God bless him and your family write him in wAsPP +31612574318) 01010101010101010101010101010101010616431213131645456464212453464613515454546454646454876424512131345546454546464646464613131242454849464645653131213131312121554545545421545454215454545454545454546434343121313121213457846
Atara Biotherapeutics Inc - Currently Maintains Account At Svb Holding Cash Deposits Of About $2 Million
soon $2.83
today announced a collaboration with Pierre Fabre! stock going down...
why this stock always has a hard selloff on good news?
this stock is a good stock, the good run will come.
. its price is $ 1
Does this stock go up, or does it always go down?
Atara Biotherapeutics' Ebvallo Receives Approval Recommendation from CHMP👏👏👏🎉🥳🥳🥳🥳🥳🥳🥳
🚀
only short!
3,40-3,00 ..
4.75...4.40...after 🚀
only short!!
my target- 70$
BRIEF-Atara Biotherapeutics - Entered Into Sales Agreement For Offering Of Up To $100 MillionNov 26 (Reuters) - Atara Biotherapeutics Inc:* ATARA BIOTHERAPEUTICS - ENTERED INTO SALES AGREEMENT FOR OFFERING OF UP TO $100 MILLION
trash ?
What has happened to ATRA?
What has happened to ATRA?
Issues more stocks
what has happened?
🚀🔥Requires reading! Bayer pays Atara bio $ atra an advance of $ 60mil and potentially $ 600 mil + royalties with a percentage of future sales towards its target Mesothelin. They enter into strategic partnerships 🚀🔥 - we are waiting for the opening of 🇷🇺 our session and the US session 🇺🇸. There should be a jerk up 🚀, pumps and gaps with closure are possible.
According to IR, $ATRA won't be issuing secondary any time soon. Possibly after the successful Phase 3 test.. It's a BUY!
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.